Results 151 to 160 of about 110,777 (250)

Duration of intensive care unit stay as a guide for the timely treatment of Carbapenem-resistant <i>Enterobacterales</i> bloodstream infection: a case-control study. [PDF]

Antimicrob Steward Healthc Epidemiol
Karadoğan E, Uzar H, Özden A, Dalgıç B, Demir M, Sertçelik A, Telli Dizman G, Çakır B, Hazırolan G, Uzun O, Metan G.   +10 more
europepmc   +1 more source

Mechanisms of resistance to the carbapenems

, 1995
David Livingstone, M. John Gill, Robert A. Wise   +2 more
openalex   +1 more source

Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece [PDF]

, 2000
Angeliki Mavroidi
openalex   +1 more source

Structural insights into the activity of carbapenemases: understanding the mechanism of action of current inhibitors and informing the design of new carbapenem adjuvants. [PDF]

RSC Med Chem
Hatzisarantinos T, Mansour E, Du JJ, Fares M, Hibbs DE, Groundwater PW.   +5 more
europepmc   +1 more source

Novel C-2 Substituted Carbapenem Derivatives. Part II. Synthesis and Structure-activity Relationships of Isoxazolin-2-yl, Isoxazolidin-2-yl and 2-Pyrazolin-2-yl Carbapenems Generated Using 1,3-Dipolar Cycloaddition Chemistry.

, 1996
George Burton, GRAHAM J. CLARKE, James Douglas, A. J. EGLINGTON, COLIN H. FRYDRYCH, JEREMY D. MINKS, Nicholas W. Hird, ERIC HUNT, Stephen F. Moss, A. Naylor, Neville Nicholson, Michael J. Pearson   +11 more
openalex   +2 more sources

2025 ACVIM Forum Research Report Program

Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Whole-genome sequencing reveals resistance mechanisms and molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa bloodstream infections. [PDF]

BMC Microbiol
Guo Y, Hao Y, Huang M, Sun Y, Tao Z, Liu Y, Huang S, Liu P, Wei D.   +8 more
europepmc   +1 more source

The Effect of 1.BETA.-Methyl Substituent and the Basicity in C-2 Side Chain in Carbapenem Antibiotics on the Activity against Pseudomonas aeruginosa oprD2 and nalB Mutants.

, 1995
Yoshihiro Sumita, HIROSHI YAMAGA, Makoto Sunagawa   +2 more
openalex   +2 more sources

Efficacies of Imipenem, Meropenem, Cefepime, and Ceftazidime in Rats with Experimental Pneumonia Due to a Carbapenem-Hydrolyzing β-Lactamase-Producing Strain of Enterobacter cloacae [PDF]

, 2000
Olivier Mimoz, Sophie Léotard, Anne Jacolot, Christophe Padoin, K. Louchahi, Olivier Petitjean, Patrice Nordmann   +6 more
openalex   +1 more source

The impact of carbapenem-resistant infections in intensive care units: focus on non-fermenting gram-negative bacilli and survival analysis. [PDF]

Antimicrob Resist Infect Control
Dessemon J, Vacheron CH, Savey A, Machut A, Friggeri A, Prevot C, Bourge X, Lepape A, Elias C, REA-REZO Study Group.   +9 more
europepmc   +1 more source